ECOR vs RCEL โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RCEL Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avita Medical, Inc. Common Stock (RCEL) driven by superior Valuation, Momentum & Technical, Options & Structure while ECOR counters with relative strength in Growth & Margin. Fundamentally, ECOR trades at N/M Forward P/E with -33.1% operating margin (+11.5% YoY revenue) versus RCEL at 10.3x Forward P/E and -33.9% operating margin (+53.1% YoY). In options structure, ECOR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against RCEL sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ECOR Revenue | RCEL Revenue | ECOR Op. Margin | RCEL Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | $0M | -5494.1% | -1489.9% | RCEL |
| FY2019 | $0M | $10M | -1928.2% | -466.4% | RCEL |
| FY2020 | $0M | $10M | -707.9% | -299.2% | RCEL |
| FY2021 | $10M | $30M | -367.7% | -90.8% | RCEL |
| FY2022 | $10M | $30M | -266.2% | -79.9% | RCEL |
| FY2023 | $20M | $50M | -120.2% | -85.1% | RCEL |
| FY2024 | $30M | $60M | -48.3% | -88.1% | ECOR |
| FY2025 | $30M | $70M | -41.1% | -59.4% | ECOR |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ECOR | RCEL | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $44.7M | $506.7M | Larger Scale | RCEL |
| Trailing P/E Ratio Valuation | N/M | 10.3x | Lower Multiple | RCEL |
| Forward P/E Ratio Valuation | N/M | 10.3x | Lower Multiple | RCEL |
| Revenue Growth (YoY) Growth | +11.5% | +53.1% | Higher Growth | RCEL |
| Operating Margin (TTM) Profitability | -33.1% | -33.9% | Higher Margin | ECOR |
| Net Profit Margin Profitability | -33.5% | -42.6% | Higher Margin | ECOR |
| Return on Equity (ROE) Capital Efficiency | -478.7% | -1746.3% | Higher ROE | ECOR |
| 52-Week Range Position Momentum | 6% ($4โ$13) | 82% ($3โ$18) | Stronger Trend | RCEL |
| Beta / 30D Volatility Risk Regime | 1.55ฮฒ ยท 155% Vol | 1.54ฮฒ ยท 65% Vol | Lower Realized Risk | RCEL |
| Unified Institutional Score Composite Signal | 44.5 / 100 (HOLD) | 45.6 / 100 (HOLD) | Higher Composite | RCEL |